606750414	606750414	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
50800676	50800676	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2335558	2335558	CD	B-NP	O
|	|	CC	I-NP	O
9/17/2005	9/17/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
infected	infected	JJ	I-NP	O
lt.	lt.	NN	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
|	|	NN	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/17/2005	9/17/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/3/2005	10/3/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KELLEY	KELLEY	NNP	B-NP	O
,	,	,	O	O
IRWIN	IRWIN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Orthopedic	Orthopedic	NNP	B-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Infected	Infected	JJ	B-NP	O
left	left	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
PROCEDURE	PROCEDURE	NN	I-NP	O
:	:	:	O	O
Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
cemented	cemented	JJ	I-NP	O
left	left	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
and	and	CC	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic-impregnated	antibiotic-impregnated	JJ	B-NP	O
cement	cement	NN	I-NP	O
spacers	spacer	NNS	I-NP	O
on	on	IN	B-PP	O
2/16/05	2/16/05	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Beish	Beish	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
46-year-old	46-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
who	who	WP	B-NP	O
initially	initially	RB	B-ADVP	O
sustained	sustain	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
intertrochanteric	intertrochanteric	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2004	2004	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
ORIF	ORIF	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
DHS	DHS	NN	I-NP	B-DNA
on	on	IN	B-PP	O
10/15/04	10/15/04	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
screw	screw	NN	I-NP	O
ultimately	ultimately	RB	B-ADVP	O
cut	cut	VBD	B-VP	O
off	off	RP	B-PRT	O
and	and	CC	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
hardware	hardware	NN	B-NP	O
on	on	IN	B-PP	O
9/28/04	9/28/04	CD	B-NP	O
with	with	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hemiarthroplasty	hemiarthroplasty	NN	I-NP	O
with	with	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
beads	bead	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
coag-negative	coag-negative	JJ	B-NP	O
staph	staph	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
hip	hip	NN	I-NP	O
aspirations	aspiration	NNS	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
joint	joint	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
infected	infect	VBN	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
on	on	IN	B-PP	O
8/15/04	8/15/04	CD	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sweis	Sweis	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ended	end	VBD	B-VP	O
up	up	RP	B-PRT	O
being	be	VBG	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
in	in	IN	B-PP	O
Gassonvenchand	Gassonvenchand	NNP	B-NP	O
Pendinea	Pendinea	NNP	I-NP	O
Port	Port	NNP	I-NP	O
from	from	IN	B-PP	O
3/5/05	3/5/05	CD	B-NP	O
to	to	TO	B-PP	O
8/16/05	8/16/05	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
that	that	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
at	at	IN	B-PP	O
C6-C7	C6-C7	NN	B-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
C6-C7	C6-C7	NN	I-NP	B-DNA
I	I	CD	I-NP	O
&	&	CC	I-NP	O
D	D	NN	I-NP	O
infusion	infusion	NN	I-NP	O
on	on	IN	B-PP	O
5/24/05	5/24/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
completed	complete	VBD	B-VP	O
16	16	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
MRSA	MRSA	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
completion	completion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
minocycline	minocycline	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
six-month	six-month	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Amoako	Amoako	NNP	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
on	on	IN	B-PP	O
7/13/05	7/13/05	CD	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
left	left	JJ	I-NP	B-protein
groin/hip/lateral	groin/hip/lateral	JJ	I-NP	I-protein
thigh	thigh	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
over	over	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
duration	duration	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
aspirates	aspirate	NNS	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
grew	grow	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
explant	explant	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
spacer	spacer	NN	I-NP	O
on	on	IN	B-PP	O
2/16/05	2/16/05	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	B-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Myasthenia	Myasthenia	NNP	B-NP	O
gravis	gravi	VBZ	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Steroid-dependent	Steroid-dependent	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
intubations	intubation	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
young	young	JJ	I-NP	O
adult	adult	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
bleeds	bleed	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1980	1980	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

DVT	DVT	NN	B-NP	O
and	and	CC	I-NP	O
PE	PE	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-DNA
CPAP	CPAP	NN	I-NP	I-DNA
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Osteoporosis	Osteoporosis	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Diverticulitis	Diverticulitis	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Migraines	Migraine	NNS	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Cervical	Cervical	JJ	B-NP	O
discitis	discitis	NN	I-NP	O
and	and	CC	O	O
vertebral	vertebral	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
hip	hip	NN	I-NP	O
DHS	DHS	NN	I-NP	O
,	,	,	O	O
10/15/04	10/15/04	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
hardware	hardware	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
hip	hip	NN	B-NP	O
with	with	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
hemiarthroplasty	hemiarthroplasty	NN	B-NP	O
with	with	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
spacer	spacer	NN	I-NP	O
on	on	IN	B-PP	O
9/28/04	9/28/04	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Revision	Revision	NN	B-NP	O
left	leave	VBD	B-VP	O
total	total	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
on	on	IN	B-PP	O
11/8/04	11/8/04	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

I	I	PRP	B-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
with	with	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
fusion	fusion	NN	I-NP	O
,	,	,	O	O
5/24/05	5/24/05	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Arthroscopic	Arthroscopic	JJ	B-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
I	I	CD	I-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
,	,	,	O	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Partial	Partial	JJ	B-NP	O
colectomy/oophorectomy	colectomy/oophorectomy	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Cholecystectomy	Cholecystectomy	NN	B-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

OxyContin	OxyContin	NN	B-NP	O
80	80	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	B-protein
p.o.	p.o.	FW	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Fioricet	Fioricet	VB	B-VP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	B-protein
p.o.	p.o.	FW	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Fentanyl	Fentanyl	NN	B-NP	B-protein
patch	patch	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
72	72	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Minocycline	Minocycline	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Singular	Singular	JJ	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Reglan	Reglan	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Os-Cal	Os-Cal	JJ	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Lexapro	Lexapro	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Mestinon	Mestinon	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Mirtazapine	Mirtazapine	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Zofran	Zofran	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Advair	Advair	NN	B-NP	O
500/50	500/50	CD	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Albuterol/ipratropium	Albuterol/ipratropium	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Imitrex	Imitrex	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
vomiting	vomit	VBG	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Vicodin	Vicodin	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
vomiting	vomit	VBG	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
dye	dye	NN	I-NP	O
causes	cause	VBZ	B-VP	O
throat	throat	DT	B-NP	O
burning	burning	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
single	single	JJ	B-ADJP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
Utah	Utah	NNP	B-NP	O
She	She	NNP	I-NP	O
quit	quit	VBD	B-VP	O
smoking	smoking	NN	B-NP	O
tobacco	tobacco	NN	I-NP	O
25	25	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
ambulates	ambulate	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
antalgic	antalgic	JJ	I-NP	O
gait	gait	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
palpation	palpation	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mid	mid	JJ	I-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
distal	distal	JJ	I-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
proximal	proximal	JJ	B-ADJP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

Gentle	Gentle	NN	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
left	left	JJ	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
caused	cause	VBD	B-VP	I-protein
pain	pain	NN	B-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
1/9/05	1/9/05	CD	B-NP	O
for	for	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
request	request	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Willy	Willy	NNP	I-NP	O
H	H	NNP	I-NP	O
Kirkey	Kirkey	NNP	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
slight	slight	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
performed	perform	VBN	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

Preoperatively	Preoperatively	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	DT	B-NP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-dose	low-dose	JJ	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	B-VP	O
likely	likely	RB	I-VP	O
add	add	VB	I-VP	O
little	little	JJ	B-NP	O
benefit	benefit	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
before	before	IN	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
preparation	preparation	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
irrigation	irrigation	NN	B-NP	O
,	,	,	I-NP	O
debridement	debridement	NN	I-NP	O
and	and	CC	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
spacer	spacer	NN	I-NP	O
.	.	.	O	O

Estimated	Estimate	VBN	B-NP	O
blood	blood	NN	I-NP	O
loss	loss	NN	I-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
six	six	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
9	9	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
crystalloid	crystalloid	JJ	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
albumin	albumin	NN	B-NP	B-protein
.	.	.	O	O

Intraoperatively	Intraoperatively	RB	B-ADVP	O
,	,	,	O	O
gross	gross	JJ	B-NP	O
pus	pus	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Intraoperative	Intraoperative	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
grew	grow	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
perioperative	perioperative	JJ	B-NP	O
stress	stress	NN	I-NP	O
dose	dose	NN	I-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
and	and	CC	O	O
intubated	intubate	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
29.2	29.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
intubated	intubated	JJ	B-ADJP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
open	open	VB	I-VP	O
her	her	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
and	and	CC	O	O
follow	follow	JJ	B-NP	O
commands	command	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
neurovascularly	neurovascularly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
only	only	RB	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
initially	initially	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
p.o.	p.o.	NN	B-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
administered	administer	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
had	have	VBD	B-VP	O
drifted	drift	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
22.4	22.4	CD	B-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
26.2	26.2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
neurovascularly	neurovascularly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
p.o.	p.o.	NN	B-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
Mestinon	Mestinon	NNP	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
myasthenia	myasthenia	NN	I-NP	O
gravis	gravis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
mid	mid	JJ	B-NP	O
morning	morning	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dressing	dressing	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
incision	incision	NN	I-NP	O
was	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
until	until	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
mainly	mainly	RB	B-ADVP	O
with	with	IN	B-PP	O
continued	continued	JJ	B-NP	O
pain	pain	NN	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
Dilaudid	Dilaudid	JJ	B-NP	B-protein
PCA	PCA	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clear	clear	JJ	B-NP	O
diet	diet	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
a.m.	a.m.	NN	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
right	right	JJ	I-NP	I-cell_line
IJ	IJ	NN	I-NP	I-cell_line
central	central	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
out	out	RP	B-PRT	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
wire	wire	NN	I-NP	O
under	under	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
technique	technique	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
lat	lat	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
p.o.	p.o.	NN	B-NP	O
's	's	POS	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
.	.	.	O	O

Postoperative	Postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
her	her	PRP$	B-NP	O
main	main	JJ	I-NP	O
issue	issue	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Chronic	Chronic	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
on	on	IN	B-PP	O
transitioning	transitione	VBG	B-VP	O
her	her	PRP$	B-NP	O
off	off	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
high-dose	high-dose	JJ	I-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
PCA	PCA	NN	I-NP	O
.	.	.	O	O

PCA	PCA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
oxycodone	oxycodone	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
and	and	CC	I-NP	O
OxyContin	OxyContin	NN	I-NP	B-protein
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
worked	work	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
first	first	RB	I-VP	O
sit	sit	VB	I-VP	O
her	her	PRP$	B-NP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
edge	edge	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
neurovascularly	neurovascularly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
5	5	CD	I-NP	O
for	for	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
long-term	long-term	JJ	I-NP	O
IV	IV	CD	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
titrate	titrate	VB	B-VP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
with	with	IN	B-PP	O
gradually	gradually	RB	B-ADVP	O
improving	improve	VBG	B-VP	O
effect	effect	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
around	around	IN	B-PP	O
a	a	DT	B-NP	O
little	little	RB	I-NP	O
more	more	RBR	B-ADVP	O
easily	easily	RB	I-ADVP	O
.	.	.	O	O

By	By	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
comfortable	comfortable	JJ	I-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
voiding	void	VBG	B-VP	O
q.	q.	NN	B-NP	O
shift	shift	NN	I-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
neurovascularly	neurovascularly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
both	both	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
not	not	RB	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
bridge	bridge	NN	I-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
7	7	CD	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Orthopedic	Orthopedic	JJ	I-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
and	and	CC	O	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
accepted	accept	VBN	I-VP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Biger	Biger	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
Ee	Ee	NNP	B-NP	O
,	,	,	O	O
Side	Side	NNP	B-NP	O
Lin	Lin	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	B-protein
650	650	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Erythropoietin	Erythropoietin	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Fentanyl	Fentanyl	NN	B-NP	B-protein
patch	patch	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
72	72	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcu	subcu	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Reglan	Reglan	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Mestinon	Mestinon	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
1.5	1.5	CD	I-NP	O
gm	gm	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
h.	h.	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
more	more	JJR	I-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
total	total	JJ	B-ADJP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
13	13	CD	I-NP	I-protein
.	.	.	O	O

OxyContin	OxyContin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Dilaudid	Dilaudid	VBD	B-VP	O
10	10	CD	B-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
2	2	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Clonidine	Clonidine	NN	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Mirtazapine	Mirtazapine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Singular	Singular	JJ	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	RB	B-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NNP	B-NP	O
600	600	CD	I-NP	O
plus	plus	CC	O	O
D	D	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

DuoNeb	DuoNeb	IN	B-PP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
q.	q.	NN	B-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Lexapro	Lexapro	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
25	25	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
daily	daily	RB	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
as	as	IN	B-SBAR	O
planned	plan	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
8	8	CD	B-NP	O
mg	mg	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
INR	INR	NN	I-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

26	26	CD	B-NP	O
.	.	.	O	O

Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.5	1.5	CD	B-NP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
ACTIVITIES	ACTIVITIES	NNS	I-NP	O
:	:	:	O	O
Touchdown	Touchdown	IN	B-PP	O
weightbearing	weightbeare	VBG	B-VP	O
with	with	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
dislocation	dislocation	NN	I-NP	O
precautions	precaution	NNS	I-NP	O
and	and	CC	O	O
troche	troche	VB	B-VP	O
off	off	RP	B-PRT	O
precautions	precaution	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

With	With	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rabito	Rabito	NNP	I-NP	O
on	on	IN	B-PP	O
10/14/06	10/14/06	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
noon	noon	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Ockmond	Ockmond	NNP	I-NP	O
on	on	IN	B-PP	O
10/14/06	10/14/06	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
Terb	Terb	NNP	B-NP	O
Sa	Sa	NNP	I-NP	O
with	with	IN	B-PP	O
whom	whom	WP	B-NP	O
Dr.	Dr.	NNP	B-NP	O
Lance	Lance	NNP	I-NP	O
Gourdin	Gourdin	NNP	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Scotldi	Scotldi	NNP	I-NP	O
Fents	Fents	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
interacting	interact	VBG	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
local	local	JJ	I-NP	O
spine	spine	NN	I-NP	O
surgeon	surgeon	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Dry	Dry	JJ	B-NP	O
sterile	sterile	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
left	leave	VBN	I-VP	O
open	open	JJ	B-ADJP	O
to	to	TO	B-PP	O
air	air	NN	B-NP	O
when	when	WRB	B-ADVP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
staples	staple	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
10/19/05	10/19/05	CD	B-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
completely	completely	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
that	that	DT	B-NP	O
removal	removal	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
delayed	delay	VBN	I-VP	O
until	until	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
steri-stripped	steri-stripped	JJ	B-ADJP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
for	for	IN	B-PP	O
PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
q.	q.	NNP	B-NP	O
Monday	Monday	NNP	I-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
called	call	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SAMHAMC	SAMHAMC	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
107-568-5779	107-568-5779	CD	B-NP	O
extension	extension	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
with	with	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Geetiuc	Geetiuc	NNP	I-NP	O
Tars	Tar	NNPS	I-NP	B-DNA
Memorial	Memorial	NNP	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
notified	notify	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.5	1.5	CD	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
weekly	weekly	JJ	I-NP	O
CBC	CBC	NN	I-NP	O
,	,	,	I-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
vancomycin	vancomycin	NN	B-NP	O
trough	trough	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-8418296	8-8418296	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MUMA	MUMA	NNP	B-NP	O
,	,	,	O	O
EVERETTE	EVERETTE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GEMMA	GEMMA	NNP	B-NP	O
,	,	,	O	O
AVERY	AVERY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4637403	4637403	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/29/05	5/29/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/29/05	5/29/05	CD	B-NP	O

